Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids
We retrospectively identified 89 consecutive patients from January 2004 to January 2012 to investigate efficacy of direct intrahepatic portocaval shunt (DIPS) combined with inferior vena cava (IVC) stenting for sinusoidal obstruction syndrome (SOS) associated with hepatotoxicity of pyrrolizidine alk...
Main Authors: | Shihua Luo, Jianguo Chu, He Huang, Kechun Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/9804582 |
Similar Items
Similar Items
-
Hepatotoxicity of Pyrrolizidine Alkaloids
by: Manuela G Neuman, et al.
Published: (2015-11-01) -
Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome
by: Mark R. Pedersen, M.D., et al.
Published: (2016-01-01) -
Transjugular intrahepatic portocaval shunting as a preparation phase for liver transplantation
by: P. G. Tarazov, et al.
Published: (2018-08-01) -
First Report of Fulminant Budd-Chiari Syndrome Treated by Direct Intrahepatic Portocaval Shunt in Vietnam
by: Thai Van Nguyen, et al.
Published: (2021-09-01) -
Pyrrolizidine alkaloids: An update on their metabolism and hepatotoxicity mechanism
by: Jie Xu, et al.
Published: (2019-12-01)